UC-MSCs had significantly higher potential of steroidogenic differentiation than BM-MSCs; thus, UC-MSCs could be favourable cells of choice for cell-based therapy for steroidogenic insufficiency compared to BM-MSCs.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: